SEC Company Response from Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306) (TNXP) — Aug 6, 2013
Tonix Pharmaceuticals Holding Corp. (TNXP) (CIK 0001430306)
Date: Aug. 6, 2013 · CIK: 0001430306 · Accession: 0001144204-13-043444
AI Filing Summary & Sentiment
File numbers found in text: 333-188547
Show Raw Text
CORRESP
1
filename1.htm
Roth Capital Partners, LLC
888 San Clemente Drive
Newport Beach, CA 92660
National Securities Corporation
120 Broadway, 27th Floor
New York, NY 10271
Dawson James Securities, Inc.
1 North Federal Highway, 5th Floor
Boca Raton, FL 33432
August 6, 2013
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Tonix Pharmaceuticals Holding
Corp. (the “Company”)
Registration Statement on Form S-1
(File No. 333-188547)
Ladies and Gentlemen:
In connection with the above-captioned
registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned
hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 4:00 p.m. (New
York Time) on Thursday, August 8, 2013, or as soon thereafter as practicable.
In making this request the undersigned
acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to
the registration statement.
Very truly yours,
Roth Capital Partners, LLC
NATIONAL SECURITIES CORPORATION
By:
/s/ Aaron Gurewitz
By:
/s/ Jonathan Rich
Name:
Aaron Gurewitz
Name:
Jonathan Rich
Title:
Head of Equity Capital Markets
Title:
Head of Investment Banking
DAWSON JAMES SECURITIES, INC.
By:
/s/ Bob Keyser
Name:
Bob Keyser
Title:
Chief Executive Officer